These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 30869817

  • 1. Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia.
    Ikeda J, Shiba N, Tsujimoto SI, Yoshida M, Nakabayashi K, Ogata-Kawata H, Okamura K, Takeuchi M, Osumi T, Tomizawa D, Hata K, Kiyokawa N, Ito S, Kato M.
    Genes Chromosomes Cancer; 2019 Sep; 58(9):669-672. PubMed ID: 30869817
    [Abstract] [Full Text] [Related]

  • 2. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia.
    Blackburn PR, Smadbeck JB, Znoyko I, Webley MR, Pitel BA, Vasmatzis G, Xu X, Greipp PT, Hoppman NL, Ketterling RP, Baughn LB, Lindsey KG, Schandl CA, Wolff DJ, Peterson JF.
    Genes Chromosomes Cancer; 2020 Jul; 59(7):422-427. PubMed ID: 32196814
    [Abstract] [Full Text] [Related]

  • 3. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
    Peterson JF, Sukov WR, Pitel BA, Smoley SA, Pearce KE, Meyer RG, Williamson CM, Smadbeck JB, Vasmatzis G, Hoppman NL, Greipp PT, Baughn LB, Ketterling RP.
    Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
    [Abstract] [Full Text] [Related]

  • 4. Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration study.
    Zerkalenkova E, Lebedeva S, Kazakova A, Tsaur G, Starichkova Y, Timofeeva N, Soldatkina O, Aprelova E, Popov A, Ponomareva N, Baidun L, Meyer C, Novichkova G, Maschan M, Maschan A, Marschalek R, Olshanskaya Y.
    Int J Lab Hematol; 2019 Apr; 41(2):287-292. PubMed ID: 30624859
    [Abstract] [Full Text] [Related]

  • 5. Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
    Miyamura T, Kudo K, Tabuchi K, Ishida H, Tomizawa D, Adachi S, Goto H, Yoshida N, Inoue M, Koh K, Sasahara Y, Fujita N, Kakuda H, Noguchi M, Hiwatari M, Hashii Y, Kato K, Atsuta Y, Okamoto Y.
    Leuk Res; 2019 Dec; 87():106263. PubMed ID: 31707119
    [Abstract] [Full Text] [Related]

  • 6. Therapy-induced Deletion in 11q23 Leading to Fusion of KMT2A With ARHGEF12 and Development of B Lineage Acute Lymphoplastic Leukemia in a Child Treated for Acute Myeloid Leukemia Caused by t(9;11)(p21;q23)/KMT2A-MLLT3.
    Panagopoulos I, Andersen K, Eilert-Olsen M, Zeller B, Munthe-Kaas MC, Buechner J, Osnes LTN, Micci F, Heim S.
    Cancer Genomics Proteomics; 2021 Dec; 18(1):67-81. PubMed ID: 33419897
    [Abstract] [Full Text] [Related]

  • 7. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
    Ney Garcia DR, de Souza MT, de Figueiredo AF, Othman MAK, Rittscher K, Abdelhay E, Capela de Matos RR, Meyer C, Marschalek R, Land MGP, Liehr T, Ribeiro RC, Silva MLM.
    Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
    [Abstract] [Full Text] [Related]

  • 8. KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia.
    Kanayama T, Imamura T, Kawabe Y, Osone S, Tahara J, Iwasaki F, Miyagawa N, Goto H, Imashuku S, Hosoi H.
    Int J Hematol; 2018 Dec; 108(6):665-669. PubMed ID: 30143999
    [Abstract] [Full Text] [Related]

  • 9. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A.
    Bill M, Mrózek K, Kohlschmidt J, Eisfeld AK, Walker CJ, Nicolet D, Papaioannou D, Blachly JS, Orwick S, Carroll AJ, Kolitz JE, Powell BL, Stone RM, de la Chapelle A, Byrd JC, Bloomfield CD.
    Proc Natl Acad Sci U S A; 2020 Oct 20; 117(42):26340-26346. PubMed ID: 33020282
    [Abstract] [Full Text] [Related]

  • 10. Recent Developments and Evolving Therapeutic Strategies in KMT2A-Rearranged Acute Leukemia.
    Yin L, Wan L, Zhang Y, Hua S, Shao X.
    Cancer Med; 2024 Oct 20; 13(20):e70326. PubMed ID: 39428967
    [Abstract] [Full Text] [Related]

  • 11. The Application of Targeted RNA Sequencing for KMT2A-Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia.
    Dai B, Yu H, Ma T, Lei Y, Wang J, Zhang Y, Lu J, Yan H, Jiang L, Chen B.
    J Mol Diagn; 2021 Nov 20; 23(11):1478-1490. PubMed ID: 34384895
    [Abstract] [Full Text] [Related]

  • 12. A new variant of KMT2A(MLL)-FLNA fusion transcript in acute myeloid leukemia with ins(X;11)(q28;q23q23).
    Matveeva E, Kazakova A, Olshanskaya Y, Tsaur G, Shelikhova L, Meyer C, Marschalek R, Novichkova G, Maschan M, Maschan A.
    Cancer Genet; 2015 Apr 20; 208(4):148-51. PubMed ID: 25892123
    [Abstract] [Full Text] [Related]

  • 13. Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.
    Pincez T, Landry JR, Roussy M, Jouan L, Bilodeau M, Laramée L, Couture F, Sinnett D, Gendron P, Hébert J, Oligny L, Rouette A, Tran TH, Wilhelm BT, Bittencourt H, Cellot S.
    Genes Chromosomes Cancer; 2020 Feb 20; 59(2):125-130. PubMed ID: 31515871
    [Abstract] [Full Text] [Related]

  • 14. The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia.
    Al-Kershi S, Bhayadia R, Ng M, Verboon L, Emmrich S, Gack L, Schwarzer A, Strowig T, Heckl D, Klusmann JH.
    Blood Adv; 2019 Dec 23; 3(24):4252-4263. PubMed ID: 31867596
    [Abstract] [Full Text] [Related]

  • 15. Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in KMT2A-Rearranged Acute Lymphoblastic and Myeloid Leukemia.
    Adriaanse FRS, Schneider P, Arentsen-Peters STCJM, Fonseca AMND, Stutterheim J, Pieters R, Zwaan CM, Stam RW.
    Int J Mol Sci; 2024 May 30; 25(11):. PubMed ID: 38892207
    [Abstract] [Full Text] [Related]

  • 16. A New Complex Karyotype Involving a KMT2A-r Variant Three-Way Translocation in a Rare Clinical Presentation of a Pediatric Patient with Acute Myeloid Leukemia.
    Capela de Matos RR, Ney Garcia DR, Othman MAK, Moura Ferreira G, Melo JB, Carreira IM, Meyer C, Marschalek R, Costa ES, Land MGP, Liehr T, Ribeiro RC, Silva MLM.
    Cytogenet Genome Res; 2019 May 30; 157(4):213-219. PubMed ID: 30974445
    [Abstract] [Full Text] [Related]

  • 17. Identification of a Cryptic Insertion ins(11;X)(q23;q28q12) Resulting in a KMT2A-FLNA Fusion in a 13-Month-Old Child with Acute Myelomonocytic Leukemia.
    Lentes J, Thomay K, Schneider DT, Bernbeck B, Reinhardt D, Marschalek R, Meyer C, Schlegelberger B, Göhring G.
    Cytogenet Genome Res; 2016 May 30; 150(3-4):281-286. PubMed ID: 28253492
    [Abstract] [Full Text] [Related]

  • 18. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531.
    Pollard JA, Guest E, Alonzo TA, Gerbing RB, Loken MR, Brodersen LE, Kolb EA, Aplenc R, Meshinchi S, Raimondi SC, Hirsch B, Gamis AS.
    J Clin Oncol; 2021 Oct 01; 39(28):3149-3160. PubMed ID: 34048275
    [Abstract] [Full Text] [Related]

  • 19. GAS6 Oncogene and Reverse MLLT3-KMT2A Duplications in an Infant with Acute Myeloid Leukemia and a Novel Complex Hyperdiploid Karyotype: Detailed High-Resolution Molecular Cytogenetic Studies.
    Capela de Matos RR, Ney Garcia DR, Cifoni E, Othman MAK, Tavares de Souza M, Carboni EK, Ferreira GM, Liehr T, Ribeiro RC, M Silva ML.
    Cytogenet Genome Res; 2017 Oct 01; 152(1):33-37. PubMed ID: 28595195
    [Abstract] [Full Text] [Related]

  • 20. Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia.
    Vetro C, Haferlach T, Meggendorfer M, Stengel A, Jeromin S, Kern W, Haferlach C.
    Cancer Genet; 2020 Jan 01; 240():15-22. PubMed ID: 31698332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.